Literature DB >> 16773272

Follow-up of a large population of asymptomatic/oligosymptomatic hyperckemic subjects.

Elisabetta D'Adda1, Monica Sciacco, Maria Elisa Fruguglietti, Veronica Crugnola, Valeria Lucchini, Filippo Martinelli-Boneschi, Chiara Zecca, Costanza Lamperti, Giacomo Pietro Comi, Nereo Bresolin, Maurizio Moggio, Alessandro Prelle.   

Abstract

Six years before the present study we performed a retrospective study of 114 subjects presenting with asymptomatic / oligosymptomatic hyperckemia (raised creatine kinase blood levels), a diagnosis being made in 21 of them. We now present the results of a long-term follow-up in 55 of the still undiagnosed 93 individuals. Most of them have remained asymptomatic and did not develop specific neuromuscular disorders. One subject became frankly symptomatic manifesting limb-girdle weakness. A diagnosis of dystrophinopathy carrier and one of possible type I SMA carrier were indirectly made in another two subjects. Almost all subjects still have hyperckemia, though the mean creatine kinase (CK) value is lower than before. CK levels have become normal in 12 subjects. Two died of neoplasia, and six developed non-neuromuscular disorders. We noted no follow-up differences in terms of CK modifications between subjects with pathological EMG and/or muscle biopsy findings and those with normal findings at first examination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773272     DOI: 10.1007/s00415-006-0223-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

1.  Serum enzyme alterations in neuromuscular disorders.

Authors:  T L Munsat; R Baloh; C M Pearson; W Fowler
Journal:  JAMA       Date:  1973-12-24       Impact factor: 56.272

2.  Factors affecting serum creatine phosphokinase levels in the general population: the role of race, activity and age.

Authors:  H Y Meltzer
Journal:  Clin Chim Acta       Date:  1971-06       Impact factor: 3.786

3.  Persistent hyperCKemia: fourteen patients studied in retrospect.

Authors:  L M Brewster; M de Visser
Journal:  Acta Neurol Scand       Date:  1988-01       Impact factor: 3.209

4.  Benign prognosis in idiopathic hyper-CK-emia.

Authors:  J C Reijneveld; N C Notermans; W H Linssen; J H Wokke
Journal:  Muscle Nerve       Date:  2000-04       Impact factor: 3.217

Review 5.  Elevated creatine kinase and malignancy.

Authors:  C Eng; A E Skolnick; S E Come
Journal:  Hosp Pract (Off Ed)       Date:  1990-12-15

6.  Idiopathic hyperCKemia.

Authors:  N Sunohara; A Takagi; I Nonaka; H Sugita; E Satoyoshi
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

7.  Heterogeneity of serum creatine kinase activity among racial and gender groups of the population.

Authors:  E T Wong; C Cobb; M K Umehara; G A Wolff; L J Haywood; T Greenberg; S T Shaw
Journal:  Am J Clin Pathol       Date:  1983-05       Impact factor: 2.493

Review 8.  Limb-girdle muscular dystrophies--from genetics to molecular pathology.

Authors:  S H Laval; K M D Bushby
Journal:  Neuropathol Appl Neurobiol       Date:  2004-04       Impact factor: 8.090

9.  Dystrophinopathy in isolated cases of myopathy in females.

Authors:  E P Hoffman; K Arahata; C Minetti; E Bonilla; L P Rowland
Journal:  Neurology       Date:  1992-05       Impact factor: 9.910

10.  Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.

Authors:  C Minetti; F Sotgia; C Bruno; P Scartezzini; P Broda; M Bado; E Masetti; M Mazzocco; A Egeo; M A Donati; D Volonte; F Galbiati; G Cordone; F D Bricarelli; M P Lisanti; F Zara
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

View more
  4 in total

1.  Asymptomatic hyperCKemia during a two-year monitoring period: A case report and literature overview.

Authors:  Spyridon Klinis; Athanasios Symeonidis; Dimitrios Karanasios; Emmanouil K Symvoulakis
Journal:  Biomed Rep       Date:  2016-11-30

2.  Hypertension risk in idiopathic hyperCKemia.

Authors:  Lizzy M Brewster; Sjoerd van Bree; Jaap C Reijneveld; Nicolette C Notermans; W M Monique Verschuren; Joseph F Clark; Gert A van Montfrans; Marianne de Visser
Journal:  J Neurol       Date:  2008-01-22       Impact factor: 4.849

Review 3.  Approach to asymptomatic creatine kinase elevation.

Authors:  Siamak Moghadam-Kia; Chester V Oddis; Rohit Aggarwal
Journal:  Cleve Clin J Med       Date:  2016-01       Impact factor: 2.321

4.  Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing.

Authors:  Shuai Han; Hong Xu; Jinxian Zheng; Junhui Sun; Xue Feng; Yue Wang; Wen Ye; Qing Ke; Yanwei Ren; Shulie Yao; Songying Zhang; Jianfen Chen; Robert C Griggs; Zhengyan Zhao; Ming Qi; Michele A Gatheridge
Journal:  Biomed Res Int       Date:  2020-09-27       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.